+2 year(s) experience
Ines produces opinion pieces on the treatment trends and pipeline developments in both neurology and psychiatry indications.
While her first project with us was in chronic heart failure, her current focus is on the coverage and analysis of CNS disease markets.She is committed to understanding highly dynamic rare diseases markets. Her diverse background includes experience in regulatory affairs, academic research and even community pharmacy.Before joining Datamonitor Healthcare in 2015, Ines completed a Master’s degree in Pharmaceutical Sciences.
Ines Writes For
By Ines Guerra 09 Nov 2016
Generating over 80% of multiple sclerosis (MS) sales in 2025, the US will dictate the overall market dynamics during the entire forecast period.
Topics Research wire
20 Sep 2016
16 Sep 2016